NasdaqGS - Delayed Quote • USD
Royalty Pharma plc (RPRX)
At close: 4:00 PM EDT
After hours: 5:32 PM EDT
| Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
|---|---|---|---|---|---|---|---|---|---|---|
| RPRX240517C00035000 | 3/27/2024 1:30 PM | 2024-05-17 | 0.30 | 0.00 | 0.75 | 0.00 | 0.00% | 2 | 7 | 78.91% |
| RPRX240621C00035000 | 4/26/2024 4:18 PM | 2024-06-21 | 0.05 | 0.05 | 0.50 | -0.30 | -85.71% | 1 | 127 | 53.71% |
| RPRX240719C00035000 | 4/15/2024 7:05 PM | 2024-07-19 | 0.15 | 0.05 | 0.70 | 0.00 | 0.00% | 6 | 243 | 49.46% |
| RPRX240920C00035000 | 4/16/2024 3:01 PM | 2024-09-20 | 0.40 | 0.20 | 0.50 | 0.00 | 0.00% | 17 | 53 | 33.35% |
| RPRX241018C00035000 | 4/16/2024 5:44 PM | 2024-10-18 | 0.43 | 0.10 | 1.10 | 0.00 | 0.00% | 13 | 14 | 41.07% |
| RPRX241220C00035000 | 4/25/2024 1:37 PM | 2024-12-20 | 0.70 | 0.60 | 1.05 | 0.00 | 0.00% | 1 | 148 | 34.55% |
| Contract Name | Last Trade Date (EDT) | Expire Date | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility |
|---|---|---|---|---|---|---|---|---|---|---|
| RPRX240621P00035000 | 9/7/2023 1:51 PM | 2024-06-21 | 6.70 | 7.10 | 9.00 | 0.00 | 0.00% | 1 | 4 | 70.80% |
| RPRX240719P00035000 | 4/16/2024 5:21 PM | 2024-07-19 | 7.30 | 6.40 | 9.50 | 0.00 | 0.00% | - | 10 | 55.62% |
| RPRX240920P00035000 | 2/27/2024 2:30 PM | 2024-09-20 | 4.60 | 4.80 | 7.40 | 0.00 | 0.00% | 1 | 14 | 31.10% |
| RPRX241018P00035000 | 2/27/2024 2:30 PM | 2024-10-18 | 4.80 | 4.80 | 7.40 | 0.00 | 0.00% | - | 1 | 28.52% |
| RPRX241220P00035000 | 11/6/2023 2:59 PM | 2024-12-20 | 7.60 | 6.50 | 6.80 | 0.00 | 0.00% | 3 | 7 | 0.00% |
Related Tickers
BBIO BridgeBio Pharma, Inc.
24.88
+2.26%
GMAB Genmab A/S
28.15
+2.51%
CYTK Cytokinetics, Incorporated
65.34
+0.83%
TIL Instil Bio, Inc.
10.60
+2.02%
ROIV Roivant Sciences Ltd.
11.03
+1.38%
CLRB Cellectar Biosciences, Inc.
3.0300
+0.33%
NXTC NextCure, Inc.
1.3500
+4.65%
CTMX CytomX Therapeutics, Inc.
1.5900
-0.62%
HALO Halozyme Therapeutics, Inc.
38.57
+0.29%
SPRO Spero Therapeutics, Inc.
1.4600
+2.10%